Attendee search 

Takeda Pharma

CTTQ is a leading big pharma with integrated R&D, manufacturing, marketing, and sales in China. We are the markter leader in drugs treating liver disease and cancer in China. CTTQ is a subsidiary of Sino Biopharmaceutical Ltd., which has been listed on Hong Kong Stock Exchange since 2003. Currently CTTQ has more than 10,000 employees, with total revenue of RMB 23 billion (USD$3.2 B) in 2019.

We are looking for cooperation opportunities with pharma/biotech companies via licensing and R & D collaboration in the following areas: Innovative small molecule and biologics products in therapeutic areas of oncology, liver, infectious, respiratory, cardiovascular, and metabolic diseases, etc.

Yngzijiang Pharmaceutial Group is an integrated healthcare company in china, our business scope ranges from Pharma(small molcules，biological and TCM), Medical Device and consumer health products. With nearly 20000 employees around the world. We are the biggest private Pharmaceutial company by revenue in China, with a strong revenue growth rate in the past decade. We are open to any coopearation opportunities globally. Welcome to talk to us.

Adagene, Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Founded in 2009, Kintor Pharmaceuticals concentrates on the R&D and industrialization of “best-in-class” and “first-in-class” innovative drugs and strives to become a leading enterprise in the R&D and commercialization of innovative therapies. On 22 May 2020, Kintor Pharmaceuticals was officially listed on the Hong Kong Stock Exchange with the stock code 9939.HK.

Biopharm

Manufacturing company

generic pharmaceutical listed company

An international enterprise dedicated to the innovation, ptoduce and selling of innovative drugs

After 35 years of development, the company has established an industry pattern integrating science, industry and trade led by international trade, supported by the pharmaceutical industry, and linked by pharmaceutical business, covering the whole industrial chain including R&D, production, distribution, logistics, import and export trade, academic promotion, and technical services.